High-dose melphalan followed by radical radiotherapy for the treatment of massive plasmacytoma of the chest wall.
We report three cases of massive chest wall plasmacytoma, each greater than 10 cm in diameter, without evidence of overt myeloma, whom we treated with a combination of VAD chemotherapy consolidated by high-dose melphalan and autologous peripheral blood stem cell transplantation and radical radiotherapy. All three patients completed all components of their therapy without experiencing any major side effects and one patient has had a durable remission. The other two patients have had disease progression but at sites other than the original tumour.
Das-Gupta
E P
EP
Department of Haematology, Nottingham City Hospital, Nottingham, UK. emma.das-gupta@nottingham.ac.uk
Sidra
G M
GM
Bessell
E M
EM
Lush
R J
RJ
Byrne
J L
JL
Russell
N H
NH
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D008875:Middle Aged; D010954:Plasmacytoma / Q000188:drug therapy* / Q000532:radiotherapy; D012074:Remission Induction; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D035441:Thoracic Wall
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan